0330 AffaMed EMB march 30 time tbd
BioCentury & Getty Images

Emerging Company Profile

Mega-round meets dealmaker as CBC’s AffaMed readies to build pipeline 

Emerging Company Profile: $170M raise led by Lake Bleu gives Ji Li cash to hunt neurology, eye disorder assets  

A $170 million series B led by Lake Bleu gives BeiGene veteran Ji Li ample funding to build up the neurology and ophthalmology pipeline of CBC portfolio company AffaMed.

Mar 31, 2021 | 1:14 AM GMT

Cross-border company AffaMed now has more than $170 million in series B funding and the backing of Lake Bleu Capital to pair with its hiring of one of China’s most prominent dealmakers, Ji Li, as it seeks to build up its in-licensed pipeline of

Read the full 1173 word article

How to gain access

Continue reading with a
two-week free trial.